🇺🇸 FDA
Patent

US 8637666

Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors

granted A61PA61P25/28A61P35/00

Quick answer

US patent 8637666 (Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61P, A61P25/28, A61P35/00, A61P43/00